175 related articles for article (PubMed ID: 24394187)
1. Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues.
Godon O; Fontaine H; Kahi S; Meritet JF; Scott-Algara D; Pol S; Michel ML; Bourgine M;
Mol Ther; 2014 Mar; 22(3):675-684. PubMed ID: 24394187
[TBL] [Abstract][Full Text] [Related]
2. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.
Mancini-Bourgine M; Fontaine H; Scott-Algara D; Pol S; Bréchot C; Michel ML
Hepatology; 2004 Oct; 40(4):874-82. PubMed ID: 15382173
[TBL] [Abstract][Full Text] [Related]
3. Attempted therapeutic immunization in a chimpanzee chronic HBV carrier with a high viral load.
Shata MT; Pfahler W; Brotman B; Lee DH; Tricoche N; Murthy K; Prince AM
J Med Primatol; 2006 Jun; 35(3):165-71. PubMed ID: 16764675
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B.
Rinker F; Zimmer CL; Höner Zu Siederdissen C; Manns MP; Kraft ARM; Wedemeyer H; Björkström NK; Cornberg M
J Hepatol; 2018 Sep; 69(3):584-593. PubMed ID: 29758333
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.
Mancini-Bourgine M; Fontaine H; Bréchot C; Pol S; Michel ML
Vaccine; 2006 May; 24(21):4482-9. PubMed ID: 16310901
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.
Ren F; Hino K; Yamaguchi Y; Funatsuki K; Hayashi A; Ishiko H; Furutani M; Yamasaki T; Korenaga K; Yamashita S; Konishi T; Okita K
J Med Virol; 2003 Nov; 71(3):376-84. PubMed ID: 12966542
[TBL] [Abstract][Full Text] [Related]
7. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
[TBL] [Abstract][Full Text] [Related]
8. A pilot randomized controlled trial of dual-plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy.
Yang FQ; Yu YY; Wang GQ; Chen J; Li JH; Li YQ; Rao GR; Mo GY; Luo XR; Chen GM
J Viral Hepat; 2012 Aug; 19(8):581-93. PubMed ID: 22762143
[TBL] [Abstract][Full Text] [Related]
9. Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study.
Yang SH; Lee CG; Park SH; Im SJ; Kim YM; Son JM; Wang JS; Yoon SK; Song MK; Ambrozaitis A; Kharchenko N; Yun YD; Kim CM; Kim CY; Lee SH; Kim BM; Kim WB; Sung YC
Gene Ther; 2006 Jul; 13(14):1110-7. PubMed ID: 16525482
[TBL] [Abstract][Full Text] [Related]
10. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
[TBL] [Abstract][Full Text] [Related]
11. Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens.
Couillin I; Pol S; Mancini M; Driss F; Bréchot C; Tiollais P; Michel ML
J Infect Dis; 1999 Jul; 180(1):15-26. PubMed ID: 10353856
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice.
Yoon SK; Seo YB; Im SJ; Bae SH; Song MJ; You CR; Jang JW; Yang SH; Suh YS; Song JS; Kim BM; Kim CY; Jeong SH; Sung YC
Liver Int; 2015 Mar; 35(3):805-15. PubMed ID: 24620920
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.
Michler T; Kosinska AD; Festag J; Bunse T; Su J; Ringelhan M; Imhof H; Grimm D; Steiger K; Mogler C; Heikenwalder M; Michel ML; Guzman CA; Milstein S; Sepp-Lorenzino L; Knolle P; Protzer U
Gastroenterology; 2020 May; 158(6):1762-1775.e9. PubMed ID: 32001321
[TBL] [Abstract][Full Text] [Related]
14. Breaking B and T cell tolerance using cationic lipid--DNA complexes (CLDC) as a vaccine adjuvant with hepatitis B virus (HBV) surface antigen in transgenic mice expressing HBV.
Morrey JD; Motter NE; Chang S; Fairman J
Antiviral Res; 2011 Jun; 90(3):227-30. PubMed ID: 21545812
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
Zhou C; Peng G; Jin X; Tang J; Chen Z
Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
[TBL] [Abstract][Full Text] [Related]
16. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges.
Michel ML; Deng Q; Mancini-Bourgine M
J Hepatol; 2011 Jun; 54(6):1286-96. PubMed ID: 21238516
[TBL] [Abstract][Full Text] [Related]
18. Failure of therapeutic vaccination using hepatitis B surface antigen vaccine in the immunotolerant phase of children with chronic hepatitis B infection.
Dikici B; Bosnak M; Ucmak H; Dagli A; Ece A; Haspolat K
J Gastroenterol Hepatol; 2003 Feb; 18(2):218-22. PubMed ID: 12542609
[TBL] [Abstract][Full Text] [Related]
19. T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.
Wang Q; Sachse P; Semmo M; Lokhande M; Montani M; Dufour JF; Zoulim F; Klenerman P; Semmo N
J Viral Hepat; 2015 Dec; 22(12):1068-78. PubMed ID: 26075501
[TBL] [Abstract][Full Text] [Related]
20. A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance.
King TH; Kemmler CB; Guo Z; Mann D; Lu Y; Coeshott C; Gehring AJ; Bertoletti A; Ho ZZ; Delaney W; Gaggar A; Subramanian GM; McHutchison JG; Shrivastava S; Lee YJ; Kottilil S; Bellgrau D; Rodell T; Apelian D
PLoS One; 2014; 9(7):e101904. PubMed ID: 25051027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
